A Bio Future: Exploring Innovation in Biotechnology

4pm Event Start
4:20pm Livestream Begins

ABOUT THE EVENT

Join MassChallenge for a fireside chat that explores innovation in biotechnology. From revolutionizing healthcare to powering sustainable energy solutions, biotechnology is paving the way for transformation across various sectors and industries. 

Whether you're a corporate partner, entrepreneur, researcher, or simply passionate about biotechnology, this event offers a unique opportunity to:  

Gain insights into how biotechnology is reshaping various sectors and industries.  

Connect with industry leaders and learn about the BioTech landscape, including emerging trends, challenges, and opportunities. 

Understand the unique advantages Texas’ has in advancing biotechnology innovation.

Meet the Speakers

Janet Wu 

MassChallenge Moderator

LinkedIn

Travis McCready 

Head of Life Sciences, Industries Americas
JLL

LinkedIn

Michael Langer 

Co-Founder and Managing Partner 
T.Rx Capital

LinkedIn

Gabby Everett

Director of Business Operations & Strategy
BioLabs Pegasus Park.

LinkedIn

Jinming Gao

Professor of Biomedical Engineering at UT Southwestern Medical Center and Co-Founder of OncoNano Medicine.

LinkedIn

About our Speakers

Special guests leading the discussion are Janet Wu, business, innovation, and finance journalist, Travis McCready, Head of Life Sciences at JLL and former President & CEO of the $1.6 billion life sciences funding agency Massachusetts Life Sciences Center, and Michael Langer, Co-Founder and Managing Partner of T.Rx Capital, a Venture Capital firm focused on creation, seed, and series A investments at the intersection of technology and biology. 

Thank you to our partner Lyda Hill Philanthropies, a leader in the advancement of life science technology, for sponsoring this timely discussion. Lyda Hill deploys capital to advance science and nature through philanthropic giving and direct investments. In 2011, Lyda Hill launched a $200 million biotechnology venture fund, Remeditex Ventures, which invests in early-stage life science technology in biomedical, pharmaceuticals, diagnostics, and medical devices.